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Background: Fumonisin B1 (FB1), a mycotoxin produced by the Fusarium species, contaminates 
maize. In South Africa maize is a dietary staple and FB1 endangers human and animal health. FB1 is 
known to have neurodegenerative effects; inhibits mitochondrial respiration, causes mitochondrial 
membrane depolarization and excessive ROS production. This study investigated the antioxidant 
response in mice brain after acute (24 hrs) and prolonged (10 days) exposure to FB1. 
 
Methods: Four groups (Control acute, FB1 acute, Control prolonged, FB1 prolonged) of C57BL/6 male 
mice (n=5 per group) were used. All controls were orally administered 0.1M PBS and FB1 groups were 
administered 5mg/kg of FB1. Following acute and prolonged exposure, the mice were euthanised by 
halothane anaesthesia. Brain tissues were harvested and stored in Qiazol and Cytobuster for RNA and 
protein isolation, respectively. Protein expression of CAT, pNrf2 and Nrf2 were determined using 
western blots. The mRNA expression of Nrf2, miR-141, SOD2, GPx, Tfam, LON, SIRT3 and Tau wwere 
determined using qPCR. 
 
Results: Protein expression of Nrf2 (Acute: *p=0,0144; prolonged: **p=0,0094) and pNrf2 (acute: 
*p=0,0132; prolonged: *p=0,0462) was significantly increased upon 24 hrs and significantly decreased 
upon 10 days in tissue exposed to FB1, while mRNA levels of Nrf2  were significantly reduced upon 
acute (***p=0,0001) and prolonged (**p=0,0013) exposure. FB1 induced a significant decrease in miR-
141 levels in tissue following acute (**p=0,0019) and prolonged (***p=0,0004) exposure. FB1 
increased the protein expression of CAT in tissue following acute (p=0,1206) and significantly 
increased expression upon prolonged (**p=0,0010) exposure. FB1 also significantly increased the 
mRNA expression of GPx in acute (***p=0,0001) and prolonged (**p=0,0024) exposure. FB1 
significantly decreased the expression of SOD2 in mice brain following acute (**p=0,0070) and non-
significantly decrease upon prolonged (p=0,2725) exposure. Tfam and LONP1 levels were significantly 
decreased upon acute (***p=0,0003, ***p=0,0005) and prolonged (*p=0,0196, *p=0,0117) exposure 
to FB1 respectively. However, SIRT3 expression was decreased upon acute (p=0,0594) and significantly 
increased upon prolonged (*p=0,0283) exposure to FB1.The mRNA expression of tau was significantly 
reduced upon acute (**p=0,0054) and prolonged (*p=0,0273) exposure to FB1. 
Conclusion: FB1 compromises antioxidant and mitochondrial survival responses in mice brain. This 
may have implications in FB1-induced neurodegeneration. 
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Chapter 1 – Introduction 
 
Fumonisin B1 (FB1) is a type 2B carcinogenic mycotoxin product of ubiquitous soil fungi, Fusarium 
verticilloides and Fusarium proliferatum. It occurs worldwide as a contaminant of maize and maize 
products (Marasas 2001). In South African communities where maize is a staple food source, FB1 poses 
a serious threat to human and animal health since it is resistant to food processing methods (Scott 2012). 
FB1 has been linked to oesophageal cancer, primary liver cancer and neural tube defects among 
communities where maize is a staple food (Detrait, George et al. 2005). It is also one of the most 
recognized mycotoxins derived from F. verticilloides that has neurodegenerative effects (Domijan and 
Abramov 2011).   
FB1 can pass through the blood-brain barrier due to its high polarity and small size (Bezuidenhout, 
Gelderblom et al. 1988). The most known neurological disorder caused by exposure to fumonisins is 
equine leukoencephalomalacia (ELEM) (Brownie and Cullen 1987). Consumption of fumonisins is also 
linked with the aetiology of neuronal tube defects (NTD) in children (Marasas, Riley et al. 2004). The 
neurotoxic effects of FB1 are associated with decreased activity of glial cells (Kwon, Slikker Jr et al. 
2000), inhibition of axonal growth (Harel and Futerman 1993), impaired myelin formation and 
deposition and delayed oligodendrocyte maturation (Monnet-Tschudi, Zurich et al. 1999). Furthermore, 
FB1 has demonstrated inhibition of de novo ceramide synthesis, stimulation of astrocytes, and 
upregulation of pro-inflammatory cytokines in murine brain (Osuchowski, Edwards et al. 2005). 
On a molecular level, FB1 is known to disrupt sphingolipid metabolism in many animal species, 
including mice  (Martinova and Merrill 1995), rats (Riley, Hinton et al. 1994), pigs (Riley, An et al. 
1993), and horses (Wang, Ross et al. 1992, Riley, Showker et al. 1997). Due to FB1 structural similarity 
to sphingoid bases, it interferes with sphingolipid metabolism, leading to cytotoxicity and 
carcinogenicity  (Riley, Enongene et al. 2001). Oxidative stress has also been identified as a molecular 
mechanism of FB1 neurotoxicity (Stockmann-Juvala, Mikkola et al. 2004). The ability of FB1 to elevate 
reactive oxygen species (ROS) is rather a consequence rather than a mechanism of its toxicity. FB1 
inhibits mitochondrial complex I of the electron transport chain (ETC), decreasing the rate of 
mitochondrial and cellular respiration, increasing mitochondrial membrane depolarization and 
induction of mitochondrial ROS production (Domijan and Abramov 2011). 
Altered redox homeostasis has massive implications for neurological health, with oxidative damage 
being a common pathological mechanism in multiple neurodegenerative disorders. Cellular redox 
control is mediated by Nuclear-factor-erythroid 2 p45-Related Factor 2 (Nrf2) (López-Alarcón and 
Denicola 2013). Binding of Nrf2 to the antioxidant response element (ARE) leads to induction and 
expression of cytoprotective enzymes like glutathione S-transferase (GST), superoxide dismutase 
(SOD), heme oxygenase-1 (HO-1) and NADPH-quinone oxidase (NQO-1) (Eggler, Gay et al. 2008). 
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The presence of electrophiles and ROS activates detoxifying and antioxidant genes (Buetler, Gallagher 
et al. 1995, Hayes and Pulford 1995, Itoh, Wakabayashi et al. 2003). Disruption or inhibition of Nrf2 
has implications for cellular antioxidant response and overall health. As a consequence, Nrf2 has 
become a prime target in maintaining neurological function.  
The stability and cellular distribution of Nrf2 is tightly controlled by its inhibitory binding protein 
Kelch-like ECH-associated protein 1 (Keap1) (Itoh, Wakabayashi et al. 1999, Nguyen, Nioi et al. 2009, 
Huang, Li et al. 2015). The main role of Nrf2-Keap1 system is the regulation of cellular defence against 
environmental insults (Ishii, Itoh et al. 2000). Keap1 represses Nrf2 transactivation activity (Itoh, 
Wakabayashi et al. 1999); however, during Nrf2-signalling, the Nrf2/Keap1 complex is dissociated in 
the cytoplasm and Nrf2 translocates to the nucleus where it binds to the ARE and initiates the 
transcription of cytoprotective enzymes (Hansen, Watson et al. 2004). 
Nrf2 expression can be altered by increased free radicals or the activity of other regulatory proteins. 
Epigenetic regulation of Nrf2 provides a scarcely described mechanism of regulation. MicroRNAs 
(miRNAs) are a group of endogenous, small (18 to 25 nucleotides), noncoding RNAs that post-
transcriptionally regulate gene expression by base sequence recognition (Chen, Xu et al. 2014). 
MicroRNA-141 (miR-141) is involved in negatively regulating the expression of Keap1 and thus 
influences Nrf2 signalling (Eades, Yang et al. 2011). 
 
Considering the diverse function of Nrf2 in cellular defence and survival, establishing the role of this 
protein in FB1 induced neurotoxicity may provide a novel mechanism of FB1 toxicity. Furthermore, 
evaluating regulatory proteins or miRNA that control this pathway can uncover targeted therapeutic 
interventions.   
 
1.1  Aim & Objectives 
The aim of this study was to investigate the acute (24 hr) and prolonged (10 days) effects of FB1 on the 
Nrf2 antioxidant pathway in C57BL/6 male mice brain. It was hypothesized that FB1 altered redox 
homeostasis in the brain, thus affecting Nrf2-mediated antioxidant signalling and mitochondrial stress 
response.  
 
The objectives of this study: 
• To determine the effects of FB1 on phospho-Nrf2(S40) levels and Nrf2 protein expression in 
mouse brain at 24 hrs and 10 days 
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• To determine the effects of FB1 on the mRNA levels of Nrf2 in mice brain at 24 hrs and 10 
days 
• To investigate Nrf2-regulated antioxidant genes such as SOD2, SIRT3 and GPx in mice brain 
upon acute(24hr) and prolonged (10 days) exposure to FB1 
• To evaluate mitochondrial stress response markers in mice brain upon acute(24hr) and 
prolonged (10 days) exposure to FB1 
• To investigate the effect of FB1 on the epigenetic modulation of Nrf2 by miR-141 in mice 
brain upon acute (24 hr) and prolonged (10 days) exposure 
Research Questions: 
• Does FB1 alter Nrf2 and downstream targets in mice brain? 
• Does FB1 alter miR-141 expression in mice brain? 






















Mycotoxins, products of filamentous fungi, produced as secondary metabolites and can be toxic to 
humans and animals (da Rocha, Freire et al. 2014). Several fungal species can produce the same 
mycotoxin (Hussein and Brasel 2001).They are produced inclusively as the fungus reaches maturity, 
and they vary in size and shape, from just heterocyclic rings of up to fifty Dalton in molecular weights, 
to groups with molecular weight of greater than five hundreds Dalton in total with six to eight 
heterocyclic rings arranged unevenly (Figure 1) (da Rocha, Freire et al. 2014). These mycotoxins 
contaminate foods and feeds such as nuts, corn, rice, and cereals. This contamination can take place 
during growth and harvest in the fields as well during storage (da Rocha, Freire et al. 2014).  
 
Figure 2.1: Chemical structures of some of the commonly produced mycotoxins (Malhotra, 
Srivastava et al. 2014). 
Humans and animals are exposed to mycotoxins via direct or indirect contamination (Smith, Solomons 
et al. 1995). Humans can ingest mycotoxins through eating contaminated plant products and food 
derivatives from products such as milk, cheese, and meat (Smith, Solomons et al. 1995). Mycotoxins 
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exert several toxic effects on humans and animals including carcinogenicity, genotoxicity, 
teratogenicity, nephrotoxicity, hepatotoxicity, reproductive disorders, and immune suppression 
(Galvano, Piva et al. 2001). 
The mycotoxins that are of major public health interest are aflatoxins, fumonisins, trichothecenes, and 
ochratoxin A (Table 2.1) (Wu, Groopman et al. 2014). These mycotoxin are primary products of fungi 
of the genera Aspergillus, Fusarium, and Penicillium, which are common contaminants of food crops 
(Wu, Groopman et al. 2014).  
 
Table 2.1: Mycotoxins, Producing fungi, and Associated food/feed crops contaminated (Wu, 
Groopman et al. 2014). 
Mycotoxin Producing fungi Associated food/feed crops 
Aflatoxins Aspergillus flavus 
A. parasiticus 
Maize, peanuts, tree nuts, 
copra, 
spices, cottonseed 




Trichothecene mycotoxins F. graminearum 
F. culmorum 
Maize, wheat, barley, oats 




Maize, wheat, barley, oats, 
dried 
meats and fruits, coffee, wine 
 
2.1.1 Fumonisins 
Fumonisins are divided into 28 analogues and are categorized as A, B, C and P.  Fumonisin B (FB) is 
divided into 4 groups i.e. FB1, FB2, FB3, FB4 (Bezuidenhout, Gelderblom et al. 1988, Musser and 
Plattner 1997, Seo and Lee 1999, Omurtag 2008). They are products of numerous Fusarium species, 
primarily F. verticillioides, F. proliferatum and F. anthophilum. Fumonisins have been studied and 
found to be a contaminant of maize, rice, sorghum, beans and wheat. Approximately over 60% of all 
maize and maize based products are contaminated by fumonisins, which is unfortunate since maize is a 
staple food source to most African and South African communities (Omurtag 2008). FB1 is the most 
predominant and more toxic than FB2 and FB3 (Humpf and Voss 2004, Omurtag 2008). 
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Fumonisins are diesters of propane-1,2,3-tricarboxylic acid (TCA) and similar long-chain aminopolyol 
backbones, but FB1 is a 2S-amino-12S,16R-dimethyl-3S,5R,10R,14S,15R-pentahydroxyeicosane. It is 
also noteworthy that fumonisins have resemblance in structure with sphingoid bases sphinganine (SA) 
and sphingosine (SO) with TCA groups added at the C-14 and C-15 positions (Figure 2.2) (Humpf and 
Voss 2004). FB2 and FB3 are distinct from FB1 by the absence of the hydroxyl group at C-1 for FB2 and 
C-5 for FB3, respectively. In addition, C-5 and C-10 hydroxyl groups are absent in FB4 (Humpf and 
Voss 2004, Krska, Welzig et al. 2007). 
 
Figure 2.2: Structures and complete conformation of fumonisin B (FB) (Humpf and Voss 2004). 
Fumonisins were first isolated from cultures of F. verticilloides or F. moniliforme strain MRC 826 in 
South Africa in 1988 (Gelderblom, Jaskiewicz et al. 1988).  The isolated material of F. moniliforme 
MRC 826 from maize intended for human consumption in South Africa’s Transkei region was found 
to cause ELEM in horses (Kriek, Kellerman et al. 1981). Several studies then linked FB1 with the high 
incidence of oesophageal cancer, primary liver cancer and neural tube defects among communities 
where maize is a staple food (Detrait, George et al. 2005). FB1 was reported to fall under a class of 
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group 2B carcinogens by the International Agency for Research on Cancer (IARC) (Domijan and 
Abramov 2011). 
2.1.2 Fumonisin B1 
 
Fumonisin B1 (FB1) is one of the most recognized mycotoxins produced by F. verticiloides mould 
(Domijan and Abramov 2011). FB1 is heat-stable and cannot be destroyed by normal industrial 
processing or cooking (Creppy 2002, Scott 2012). This is of particular concern in developing countries 
with hot and humid climates that promote fungal growth. Fumonisins initially gained notoriety when it 
was associated with oesophageal cancer in communities where home-grown maize is a staple food such 
as in Transkei (South Africa), China and North Eastern Italy (Rheeder, Marasas et al. 1992, Thiel, 
Marasas et al. 1992, Peraica, Radić et al. 1999). 
FB1 is a highly polar mycotoxin enabling it to traverse cellular membranes thus enhancing toxicity 
(Bezuidenhout, Gelderblom et al. 1988, da Rocha, Freire et al. 2014). The effect of fumonisins have 
been observed on cell morphology, cell-cell interactions, function of cell-surface proteins, protein 
kinases, lipid metabolism, cell growth, regeneration, and viability (Merrill Jr, Liotta et al. 1996). 
 
2.1.3 Structure of FB1 
 
Fumonisins biochemical structure was first described in 1988, with prevalent isoforms, FB1 and FB2 
(Bezuidenhout, Gelderblom et al. 1988) (Gelderblom, Jaskiewicz et al. 1988). FB1 is a diester of 
propane 1,2,3-tricarballylic acid and 2-amino-12, 16 dimethyl-3,5,10,14,15-pentahydroxycosane 
(Figure 2.3) (Bezuidenhout, Gelderblom et al. 1988). 
 




2.1.4 Mechanism of action 
 
The structural resemblance of FB1 to the sphingoid bases is critical to its ability to disrupt sphingolipid 
metabolism (Merrill Jr, Sullards et al. 2001, Riley, Enongene et al. 2001), this is due to the primary 
amine that is responsible for its biological activity (Norred, Riley et al. 2001, Fernandez-Surumay, 
Osweiler et al. 2005).  
The similarity in structure between fumonisins and Sa and So  allows FB1 to inhibit ceramide synthase 
(Figure 2.4) (Soriano, Gonzalez et al. 2005). The Sa/So ratio maybe used as indicators of FB1 exposure 
(Soriano, Gonzalez et al. 2005). Biological activity of FB1 requires a free amino group, which makes 
FB1 and other fumonisins with primary amino groups highly toxic compared to N-acetylated 
fumonisins, which leads to inhibition of ceramide biosynthesis, free So and Sa, and reduced reacylation 
of derived So from complex sphingolipids (Abbax, Gelderblom et al. 1993, Gelderblom, Cawood et al. 
1993, Meeting 2001, Soriano, Gonzalez et al. 2005). All of these impact on cells health (Soriano, 
Gonzalez et al. 2005).  
 
 









Several studies have been conducted around the biochemical mechanisms of Fumonisin induced 
diseases in animals (Creppy 2002). Fumonisins  are type dependent when affecting animals; ELEM is 
observed in horses and rabbits (Bucci, Hansen et al. 1996, Marasas, Kellerman et al. 2014), pulmonary 
oedema and hydrothorax in pigs (Harrison, Colvin et al. 1990), and it is hepatotoxic and carcinogenic 
in rats (Gelderblom, Kriek et al. 1991). FB1 has also been shown to cause atherogenic effects in vervet 
monkeys (Fincham, Marasas et al. 1992), immunosuppression in poultry (Li, Ledoux et al. 1999) and 
brain haemorrhage in rabbits (Bucci, Hansen et al. 1996). Some studies have related FB1 with the 




The carcinogenic potential of FB1 in humans has been well established. The natural occurrence of FB1 
in home-grown maize was associated with high rates of oesophageal cancer in Africa (Rheeder, Marasas 
et al. 1992, Thiel, Marasas et al. 1992), northern Italy (Franceschi, Bidoli et al. 1990), Iran (Shephard, 
Marasas et al. 2000) and the south east of the United States (Gelderblom, Marasas et al. 1992, Rheeder, 
Marasas et al. 1992). This toxin has also been linked with primary liver cancer in some regions of 
People’s Republic of China (Chu and Li 1994, Groves, Zhang et al. 1999). 
Fumonisin have also been linked with the outbreak of foodborne disease characterized by abdominal 
pain, borborygmic and diarrhoea in a several villages in India due to exposure to contaminated corn and 
sorghum intended for human consumption (Bhat, Shetty et al. 1997). 
Neuronal tube defects (NTD) in offspring of pregnant woman consuming FB1 contaminated maize is 
also a major adverse health outcome. This is a result of malformation of neuronal tubes in the brain and 
spinal cord (WHO. 2001). A major cause of NTD is folate deficiency, which alters sphingolipid content 
of cell membranes, compromising receptors such as the folate receptor and inhibits the uptake of folate, 
leading to complications such as NTD (Sadler, Merrill et al. 2002). 
The data in the Chinese population indicate threatening levels of FB1 and other mycotoxins in corn 
samples intended for human consumption, which are capable of producing  carcinogenic nitrosamines 
that may play an important role in carcinogenesis in humans in Cixian and Linxian counties (Chu and 





2.1.5 Molecular Toxicity 
 
(A) Mitochondrial toxicity and oxidative stress 
 
Fumonisins are non-genotoxic and non-DNA reactive, hence it carcinogenic effect indirectly affects 
DNA via cellular oxidative damage (Coulombe Jr 1993, Sahu, Eppley et al. 1998, Yin, Smith et al. 
1998, Dragan, Bidlack et al. 2001). FB1  inhibits mitochondrial complex I, decreases the rate of 
mitochondrial and cellular respiration, all of which leads to mitochondrial membrane depolarization 
and induction of ROS production (Domijan and Abramov 2011). FB1 specifically targets the 
mitochondria, nucleus and nucleolus (Myburg, Needhi et al. 2009), and mitochondrial dysfunction has 
been suggested as a mechanism of FB1 cytotoxicity (Domijan and Abramov 2011). Fumonisins 
accelerate the rate of oxidation, promotion of free radical intermediate production and chain reactions 
associated with lipid peroxidation (Yin, Smith et al. 1998). FB1 induced lipid peroxidation might be an 
end result rather than a cause of FB1-induced injury (Lemmer, Gelderblom et al. 1999). 
 
(B) Cell Death and Apoptosis 
 
A 2012 study revealed that FB1 induced necrosis and apoptosis in the liver of rats (Gelderblom and 
Marasas 2012). FB1 exerts neurotoxic effects by decreasing the activity of the glial cells  (Kwon, Slikker 
Jr et al. 2000), inhibits axonal growth (Harel and Futerman 1993), impairs myelin formation and 
deposition and delays oligodendrocyte maturation (Monnet-Tschudi, Zurich et al. 1999). FB1 has been 
shown to induce an increase of free sphinganine in HT29 cells, resulting in the significant reduction in 
cell number through growth inhibition and induction of apoptosis (Schmelz, Dombrink-Kurtzman et al. 
1998). 
(C) Epigenetic effects 
 
Studies into the effect of FB1 on the epigenetic landscape have been conflicted. It has been demonstrated 
that FB1 induces a significant hypermethylation in DNA of C6 glioma cells at low concentrations 
(Mobio, Anane et al. 2000). FB1 is associated with induction of global DNA hypomethylation and 
histone demethylation in HepG2 cells (Chuturgoon, Phulukdaree et al. 2014). FB1 was also reported to 
down-regulate miR-27b in HepG2 cells, and inhibited apoptosis by upregulating the inhibitor of 
apoptosis family of proteins (Chuturgoon, Phulukdaree et al. 2014).  These studies support the role of 





 2.2 Neurotoxicity 
 
Initiation of inflammation in the brain is triggered by the activation of microglial cells and astrocytes in 
response to injuries of the central nervous system (CNS), such as those caused by neurotoxic insults 
(Monnet-Tschudi, Zurich et al. 2007). Outcomes may be determined by the level of reactivity of glial 
and primary neuronal damage. Based on conditions, the brain inflammatory response can promote 
neuroprotection, regeneration or neurodegeneration, a mystery with regard to ELEM. It has been 
established that FB1 is associated with NTD in human offspring exposed to FB1 during gestation, which 
results in abnormal neuronal tubes in the brain and spinal cord (WHO. 2001). ROS is one of the potential 
causes of neuronal damage, as the brain is more sensitive to oxidative damage (Baek, Kwon et al. 1999). 
 
2.3 Oxidative Stress 
 
Overproduction of reactive oxygen species (ROS), such as superoxide radicals, hydrogen peroxide 
(H2O2), and hydroxyl radicals can have deleterious effects on cellular health (Wang, Wang et al. 2016). 
In the event that an imbalance of pro-oxidants outweighs antioxidants, then oxidative stress results 
(Jones 2006). 
Experimental evidence supports the idea that compromised ROS homeostasis is involved in the 
development of numerous pathologies such as cardiovascular disease, neurodegenerative diseases, 
cancer and aging. The deleterious effects of free radicals depends on a number of factors, namely, the 
type of radical produced, the level, and the site of production, however, it is noteworthy that low 
concentrations of reactive species are essential to perform normal physiological functions like gene 
expression, cellular growth and defence against infection (López-Alarcón and Denicola 2013).   
ROS have been linked with aging, cancer, autoimmune and neurodegenerative disorders, as a result of 
ROS disruptive abilities towards DNA through base damage, base removal, DNA strand breaks, 
protein-DNA cross linkage, mutations, deletions and translocations (Bayr 2005, Birben, Sahiner et al. 
2012). ROS interacts with proteins, resulting in oxidation of amino acids (AA), especially sulphur-
containing AA such as cysteine and methionine leading to changes to protein structure, unfolding and 
degradation (Birben, Sahiner et al. 2012). ROS also attacks lipids, leading to lipid peroxidation via 






 2.4 Antioxidant response 
 
The transcription factor Nuclear-factor-erythroid 2 p45-Related Factor 2 (Nrf2) is a master regulator of 
the transcriptional response to oxidative stress (Solst, Rodman et al. 2017). Nrf2 is tightly linked with 
the coordination of the basal and inducible expression of antioxidant and Phase II detoxification 
enzymes that are essential for adaption to different stress conditions. Kelch-like ECH-associated protein 
1 (Keap1) regulates the stability of Nrf2 and it cellular distribution. Nrf2 activities are also controlled 
by other numerous mechanisms  such as posttranslational, transcriptional, translational and epigenetic, 
as well as by other protein partners (Nguyen, Sherratt et al. 2003, Nguyen, Nioi et al. 2009, Huang, Li 
et al. 2015).The classical pathway of Nrf2-regulated antioxidant response is via the Nrf2-Keap1 system 
as shown in Figure 2.5 (Ishii, Itoh et al. 2000).  
 
In the inhibitory complex where Keap1 directly binds Nrf2 in the cytoplasm, Keap1 represses Nrf2 
transactivation activity (Itoh, Wakabayashi et al. 1999). Under basal conditions, Keap1 ubiquitinates 
Nrf2 and localizes Nrf2 near the proteasome, thereby enhancing its degradation in the cytoplasm of 
quiescent cells. In instances of elevated cellular ROS however, the cysteine residues in the Nrf2/Keap1 
complex oxidize, allowing Nrf2 to dissociate from Keap1 and translocate to the nucleus  (Ishii, Itoh et 
al. 2000). In the nucleus, Nrf2 forms heterodimers with a group of nuclear bZIP proteins called small 
Maf proteins (Itoh, Igarashi et al. 1995). Nrf2 then induces expression of antioxidant genes via its 
interaction with regulatory DNA sequences in the antioxidant response element (ARE) (Solst, Rodman 
et al. 2017). The ARE or electrophile responsive element (EpRE) regulates the coordination in 
regulatory sites of target genes during the activation of antioxidants such as GPx, SOD, HO-1, NQO1 
(Friling, Bensimon et al. 1990, Rushmore, Morton et al. 1991, Eggler, Gay et al. 2008).  
In order for Nrf2 to be activated it has to be phosphorylated (Huang, Nguyen et al. 2002). Protein Kinase 
C (PKC) catalyses the phosphorylation of Nrf2 at Ser40; this is a critical signalling event that results in 
cellular antioxidant response mediated by ARE (Huang, Nguyen et al. 2002). Ser40 is a critical residue 
of the domain in Nrf2-Keap1 interaction believed to be part of Neh2 (comprised of ≈100 N-terminal 
amino acids), which Keap1 binds through this domain of Nrf2 and PKC phosphorylates this domain at 




Figure 2.5: Proposed model of Nrf2-mediated redox signalling (Li and Kong 2009). 
 
Detoxification of ROS is mediated by a network of antioxidant enzymes. Superoxide dismutase (SOD), 
Catalase (CAT), and Glutathione peroxidase (GPx) are the major antioxidant enzymes involved in 
radical scavenging. Superoxide dismutase acts as the first line of defence, catalysing the conversion of 





Figure 2.6: Radical scavenging activity of SOD, CAT, and GPx, starting from SIRT-3 (Prepared by 
author).  
SOD-2, also known as manganese-dependent superoxide dismutase (MnSOD), is an enzyme which in 
humans is encoded by the SOD2 gene located on chromosome 6 (Becuwe, Ennen et al. 2014). SOD2 
functions to detoxify harmful superoxide radicals, produced during mitochondrial electron transport 
chain (ETC), into H2O2 and diatomic oxygen (Becuwe, Ennen et al. 2014) thereby, lowering ROS and 
conferring  protection against cell death (Maslov, Naryzhnaia et al. 2015). 
CAT is a common enzyme found in almost all living organisms, which are exposed to oxygen, where 
it functions to catalyse the conversion of hydrogen peroxide to H2O and O2 (Figure 6) (Lobo, Patil et 
al. 2010). CAT maintains the redox balance (Wang, Wang et al. 2016).  Another antioxidant that 
detoxifies H2O2 is GPx, that uses low molecular weight thiols such as glutathione as cofactors. GPx 
contains the unique amino acid selenocytesteine in its active sites and apart from converting H2O2 to 







Sirtuin 3 (SIRT-3) is part of Sirtuin family, the mammalian homologues of the silent information 
regulator 3 (Liu, Chen et al. 2015). The encoded product of SIRT-3 is targeted to the mitochondrial 
cristae and SIRT-3 has an NAD+-dependent protein deacetylase activity (Onyango, Celic et al. 2002). 
SIRT-3 is a potential sensor NAD+/NADH ratios in the mitochondria. Elevated levels of NAD+ trigger 
a regulatory pathway that activate SIRT-3, leading to deacetylation of specific proteins (Onyango, Celic 
et al. 2002).  
SIRT-3 reduces oxidative stress, maintains levels of bioenergetics, provides stability to the 
mitochondrial membranes, and improves neuronal Ca2+ handling (Cheng, Yang et al. 2016).  SIRT-3 
protects neurons against metabolic and oxidative stresses by activating SOD2, stabilizing cellular and 
mitochondrial Ca2+ homeostasis, and prevent apoptosis. It deacetylates and  activates SOD-2, prevents 
excessive mitochondrial oxidative stress and its potential damage to cells (Cheng, Yang et al. 2016).  
SOD-2 is a direct target of SIRT-3 (Qiu, Brown et al. 2010, Tao, Coleman et al. 2010, Tao, 
Vassilopoulos et al. 2014) and a major guardian of mitochondria in neurons. Some studies have 
suggested that SIRT-3 deacetylates and activates mitochondrial enzymes involved in fatty acid β-
oxidation, amino acid metabolism, the electron transport chain, and antioxidant defences (He, Newman 
et al. 2012). 
SIRT3 have multiple functions besides being a regulator of ROS scavenging, SIRT3 deacetylates Lon 
protease 1 (LONP1/ LON) to maintain mitochondrial structure and function (Gibellini, Pinti et al. 
2014). LONP1 can be regulated by Nrf2 at a transcriptional level (Ngo, Pomatto et al. 2013). LONP1 
functions to remove and degrades oxidatively damaged proteins in the mitochondria, which results in 
the prevention of cross linking and aggregation of damaged proteins, preventing mitochondrial 
dysfunction (Ngo and Davies 2009). Furthermore, LONP1 regulates mitochondrial gene expression and 
controls mtDNA copy number by degrading mitochondrial transcription factor A (Tfam) (Lu, Lee et al. 
2013). 
Mitochondrial transcription factor A (Tfam) is essential for mtDNA maintenance, and there is a directly 
proptional relationship between mitochondrial Tfam protein levels and mtDNA copy number 
(Rantanen, Jansson et al. 2001, Noack, Bednarek et al. 2006). The in vitro studies on Tfam, indicated 
that it is regulated through nuclear respiratory factors such as Nrf1 and Nrf2 in the nucleus. (Escrivá, 
Rodríguez-Peña et al. 1999, Matsushima, Goto et al. 2010). 
 
There is a link between tau protein and oxidative stress, this link plays a huge role in the pathogenetic 
processes in neurodegenerations such as Alzheimer’s disease (AD) (Cente, Filipcik et al. 2006). 
Previously it was shown that the human shortened form of the tau protein results in elevated levels of 
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reactive oxygen species, which leads to cell death in rat cortical neurons triggered by oxidative stress. 
This shows that shortened or compromised form of tau may trigger oxidative stress in the tauopathies 




MicroRNAs (miRNAs) are 18 to 25 nucleotides long endogenous noncoding RNAs (Chen, Xu et al. 
2014). The miRNAs function in regulation of gene expression at the posttranscriptional level by binding 
to complementary sites on target mRNAs leading to either an inhibition in mRNA translation or 
Breakdown of mRNA (Figure 2.7) (He and Hannon 2004, Chen, Xu et al. 2014). MicroRNAs have 
important functional roles in brain development and neuronal requirement but their function in 
neurodegenerative diseases such as AD is unclear (Cogswell, Ward et al. 2008). 
 
  
Figure 2.7: MiRNA biosynthesis and function (He and Hannon 2004). microRNA (miRNA); pri-
microRNA (pri-miRNA); interfering RNA (siRNA)duplexes; RNA-induced silencing complex 




The variety of miRNAs and the numerous genes that are targeted by a single miRNA provide 
endogenous noncoding RNAs with multipurpose functions in the control of gene expression (Chen, Xu 
et al. 2014). The Keap1 3’-UTR have one conserved miRNA targeting site, this was recognized by 
TargetScan5.1 prediction algorithm, this site is complementary to the miR-200 family members, miR-
200a and miR-141 (which share identical seed sequences) (Eades, Yang et al. 2011). MiR-141 and miR-
200a decrease Keap1 expression disrupting the Keap1-Nrf2 complex (Eades, Yang et al. 2011). 
Furthermore, the expression of miR-141 and miR-200a are induced by oxidative stress indicating a role 
of oxidative stress in the regulation of miR-141 and miR-200a. 
 
 
2.6 Oxidative stress-induced diseases in the brain 
 
Loss of ROS homeostasis has been reported in the pathogenesis of neurodegenerative diseases such as 
Alzheimer’s disease (AD), dementia and cancer (Cente, Filipcik et al. 2006). Oxidative stress is elevated 
in the brain with AD and this may have a role in the pathogenesis of neuron degeneration and eventual 
death (Markesbery 1997). AD has been linked to mitochondrial defects affecting cytochrome-c oxidase, 
and these defects may contribute to the abnormal production of free radicals (Markesbery 1997). 
Understanding the mechanisms underlying the effects of abnormal levels of ROS in biological systems 
such as the brain can aid in therapeutic developments.  
The role of oxidative stress, miRNAs and the activation of Nrf2 in pathogenesis of neurodegenerative 
diseases and cancer in the brain are currently of interest amongst researchers. FB1 has been associated 
with cancer and neurodegenerative diseases but the underlying mechanisms by which this occurs is 
currently unclear. Therefore, the focus of this study was to investigate the effect of FB1 on oxidative 













Fumonisin B1 (FB1) (F1147) was obtained from Sigma-Aldrich (St Louis, MO, USA). Western blot 
equipment and reagents were acquired from Bio-Rad (Hercules, CA, USA). Antibodies were purchased 
from Sigma-Aldrich (St Louis, MO, USA), Abcam (Cambridge, UK) and Cell Signalling Technology 
(Danvers, MA, USA). All other reagents were obtained from Merck (Darmstadt, Germany) unless 
otherwise stated. 
3.2 Animal Treatment 
 
This study was approved by the University of KwaZulu-Natal Animal Research Ethics Committee, 
Ethics Number: AREC/079/016. Animal treatments were conducted at Nelson Mandela Campus of 
University of KwaZulu-Natal AHRI building. Four groups of C57BL/6 black male mice (n= 5 per 
group) weighing approximately 20-22g: (1) Control groups (24 hrs and 10 days), (2) FB1 24 hrs exposed 
mice, and (3) FB1 10 days exposed mice. The control groups were exposed to 0.1M PBS upon acute 
(24 hrs) and prolonged (10 days) exposure. FB1 was administered at 5mg/kg of FB1 dissolved in 0.1M 
PBS at a rate of 0.25ml/23g orally in the experimental groups. Following 24 hrs and 10 days, control 
and FB1 treated mice were sacrificed by halothane gassing. Brain tissue was harvested and rinsed in 
0.1M PBS. Samples were then cut into approximately 1cm x 1cm pieces and stored in 500µl    Qiazol 
and Cytobuster for RNA and protein isolation, respectively (Figure 3.1). All samples were stored at -




Figure 3.1: Animal treatment and brain extraction (Prepared by Author). 
Sample Preparation - Homogenisation 
Frozen samples in extraction buffers (Qiazol and Cytobuster) was done under the laminar flow hood. 
Samples were allowed to thaw on ice. Each sample was homogenised using a mechanical homogeniser 
until a slurry formed. Between each sample, the homogeniser was washed in detergent and 70% ethanol. 
Homogenates were transferred to 1.5ml microcentrifuge tubes and centrifuged (10 000 x g; 4oC; 10 
min). The supernatants were aspirated and used for further extraction. 
 
3.3 Protein expression – western blot  
 
Introduction  
Western blot is an analytical technique used to quantify the expression of a specific protein from a 
homogenous mixture of proteins extracted from cells and tissue. This procedure is based on the 
separation of proteins according to their size, transfer of these proteins to a solid support, detection of 
the proteins using immunoblotting and visualisation of protein bands using chemiluminescence (Eslami 





3.4 Protein Isolation 
 
Introduction 
Using CytobusterTM Protein Extraction Reagent (catalogue no. 71009, Novagen, Bloemfontein, SA), 
crude protein was isolated from mice brain tissue. Cytobuster is a non-ionic detergent that when 
combined with homogenisation allows for efficient extraction of soluble and functionally active 
proteins. To maintain protein integrity and prevent protein damage and degradation caused by the 
release of proteases and phosphatases during protein isolation, the Cytobuster lysis reagent is 
supplemented with a combination of protease and phosphatase inhibitors. 
Protocol 
The C57BL/6 mice brain tissues, stored in Cytobuster reagent (500μl) (Novagen, catalogue no. 71009) 
supplemented with a cocktail of protease inhibitors (Roche, catalogue no. 05892791001), were 
homogenised and centrifuged (10 000xg; 4oC; 10 min). Thereafter, the supernatant containing the crude 
protein was transferred to micro-centrifuge tubes and kept on ice. 
 
3.5 Protein quantification and standardization 
 
Principle 
Bicinchoninic acid (BCA) assay was employed to determine protein concentration. This assay relies on 
two chemical reactions that occur under alkaline conditions. The first reaction is the biuret reaction, 
which involves the reduction of cupric ions (Cu2+) to cuprous ions (Cu1+) by peptide bonds (Figure 3.2). 
This is followed by the formation of a BCA-Cu+ complex from Cu+ ions and two molecules of BCA 
reacting together producing an intense purple colour that maximally absorbs light at a wavelength of 
562nm. The amount of protein present in the sample can be measured by the intensity of the purple 
colour produced, since it is directly proportional to the number of peptide bonds participating in the 




Figure 3.2: Presentation of the BCA assay principle (prepared by author). 
Protocol 
Bovine serum albumin (BSA) standards [0, 0.2, 0.4, 0.6, 0.8 and 1mg/ml] were dissolved in distilled 
water. The standard curve was constructed using the absorbances of the BSA standards, which allowed 
the concentration of protein present in each sample to be determined. Following standard preparation, 
plating was conducted by pipetting 25μl of each standard (triplicate) and protein sample (duplicate) into 
a 96-well microtiter plate. A combination of 198μl BCA and 4μl CuSO4, forming a working solution 
(200μl) was added to each well and the plate was incubated at 37°C for 30 min. Thereafter, the 
absorbance was measure at 562nm using a spectrophotometer (Bio-tek μQuant Plate Reader).  
Proteins were standardised to a concentration of 1mg/ml in Cytobuster reagent and boiled (100oC) in 
Laemmli buffer [dH2O, 0.5M Tris-HCl (pH 6.8), glycerol, 10% SDS, 5% β-mercaptoethanol and 1% 
bromophenol blue] for 5 min. In Laemmli buffer, Tris-HCl maintains pH, glycerol adds weight to the 
samples allowing the samples to sink into the wells of the gel (Mahmood and Yang 2012), and 
bromophenol blue enables the samples to be visualised as they migrate through the gel in SDS-PAGE. 
SDS allows the proteins to be separated based on their molecular weights by denaturing and imparting 
an overall negative charge to the proteins (Mahmood and Yang 2012). The β-mercaptoethanol breaks 
disulphide bonds further denaturing proteins. All protein samples were allowed to adjust to RT prior to 
storing at -20oC.  
 




3.6 Sodium dodecyl sulphate–polyacrylamide gel electrophoresis (SDS-
PAGE) and Western Blotting 
 
Preparation of Gels for SDS-PAGE 
Introduction 
Polyacrylamide gels are a 3D polymer consisting of acrylamide and a cross-linker known as N, N’-
methylene bis-acrylamide catalysed by of ammonium persulfate (APS). SDS-PAGE employs two types 
of agarose gels to separate proteins according to their molecular weights. The upper gel, known as the 
stacking gel, is slightly acidic (pH 6.8) and contains large pores that poorly separate proteins due to its 
low polyacrylamide content (Mahmood and Yang 2012), however, the stacking gel allows the proteins 
to form thin sharply defined bands for separation by the lower resolving gel. The resolving gel is basic 
(pH 8.8), has a high polyacrylamide content and narrow pores that enable the proteins to be separated 
according to their molecular weights (Mahmood and Yang 2012). 
Protocol 
The Mini-PROTEAN Tetra Cell casting stand (BioRad) was used to prepare gels for SDS-PAGE 
(Figure 3.4). The 10% resolving gel [dH2O, 1.5M Tris (pH 8.8), 10% SDS, bis-acrylamide, 10% APS 
and TEMED] was prepared first and allowed to polymerize for 1 hr, followed by the preparation and 
addition of the 4% stacking gel [dH2O, 0.5M Tris (pH 6.8), 10% SDS, bis-acrylamide, 10% APS and 
TEMED]. A 1.5mm plastic comb was placed between the glass plates to enable the formation of wells 
for sample loading (Figure 3.3) and the gel was allowed to set for approximately 45 min. 
 




The gel cassettes were placed into the electrode tank (Mini-PROTEAN Tetra Cell System, Bio-Rad) 
and the tank was filled 1X running buffer [25mM Tris, 192mM glycine and 0.1% SDS]. The molecular 
weight marker (5μl) (Precision Plus Protein All Blue Standards, catalogue no. #161-0373, Bio-Rad) 
and protein samples (25μl) were then loaded into the wells and the samples were electrophoresed (150V, 
1.5 hrs) using the Bio-Rad compact power supply. 
 
Protein Transfer 
Following electrophoresis, proteins that were separated are transferred to a nitrocellulose membrane. 
The gels were removed from the glass plates and the stacking gel was detached leaving only the 
resolving gel. The gel together with the nitrocellulose membrane and two fibre pads were equilibrated 
in transfer buffer [25mM Tris, 192mM glycine and 20% methanol, pH 8.3] for 10 min. Following 
equilibration, a sandwich of a fibre pad, nitrocellulose membrane, gel and fibre pad was placed in the 
transfer cassette and the separated proteins were electro-transferred to the nitrocellulose membrane 
using the Trans-Blot Turbo Transfer System (30 min, 25V; Bio-Rad). The negatively charged proteins 
migrate out of the gel onto the nitrocellulose membrane due to the voltage generating an electric current 
perpendicular to the surface of the gel. 
 
Blocking and Antibody Incubation 
Following transfer, the non-specific binding of proteins was prevented by incubating (1hrs, RT) the 
membranes in 5% BSA in Tris buffered saline with 0.05% Tween 20 [TTBS; 150mM NaCl, 3mM KCl, 
25mM Tris, 0.05% Tween 20, dH2O, pH 7.5]. Thereafter, the primary antibody (Table 1) of interest 
was added to the membranes for 1 hr on the shaker at RT and then overnight at 4°C. Following the 
overnight incubation, the membranes were equilibrated to RT and washed five times with TTBS (10 
min each, RT) to remove unbound primary antibody. The membranes were then probed with the 
respective horse-radish peroxidase (HRP)-conjugated secondary antibody (Table 3.1) for 2 hrs at RT 
with gentle shaking. The specificity of the secondary antibody will allow it to bind only to the primary 
antibody of interest. Following incubation, unbound secondary antibody were removed by washing the 






Table 3.1: Antibodies, antibody dilutions and catalogue numbers. 






1:1 000 in 5% BSA Ab76026 (Abcam) 
Rabbit Anti-Nrf2 1:1 000 in 5% BSA 12721S (Cell signalling 
technology) 
Mouse Anti-CAT 1:1 000 in 5% BSA C0979 (Sigma- Aldrich) 












Anti-β-actin 1:5 000 in 5% BSA A3854 (Sigma-Aldrich) 
 
Imaging 
The antigen-antibody complex was visualised using the Clarity™ Western ECL Substrate Kit 
(catalogue no. #170-5060, Bio-Rad) and the ChemiDoc™ XRS+ Molecular Imaging System (Bio-Rad). 
The ClarityTM western ECL Substrate kit consisting of a hydrogen peroxide substrate and an enhanced 
luminol solution. The HRP conjugated to the secondary antibody reacts with the H2O2 substrate to yield 
oxygen radicals which react and degrade the luminol into aminophtalic acid. The aminophtalic acid 





Figure 3.4: Immunoblotting and protein detection (Prepared by author) 
Quenching and Normalisation 
Following detection, H2O2 (5ml) (30 min, 37°C) was used to quench the membranes. Thereafter, the 
membranes were washed once with TTBS (10 min, RT), blocked in 5% BSA in TTBS (1 hr, RT) and 
probed (30 min, RT) with the housekeeping protein, anti-β-actin (Table 1) to normalise protein 
expression. 
Image Lab Software version 5.0 (Bio-Rad) was employed to analyse protein expression and the results 
were expressed as percentage (%) fold-change and band density.  
 
3.7 Gene expression – Quantitative polymerase chain reaction 
 
Principle 
Quantitative polymerase chain reaction (qPCR) is a simple tool used to rapidly amplify specific gene 
sequences in vitro from a template strand. Two complementary oligonucleotide primers to the sites 
flanking the target region are synthesised chemically. Taq polymerase which is thermostable, 
synthesises complementary DNA (cDNA) strands by adding deoxynucleotide triphosphates (dNTPs) to 
oligonucleoside primers that are complementary to the DNA sequence flanking the target gene (Pestana, 
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Belak et al. 2010). The thermocycler is used to perform PCR where it undergoes repetitive cycling of 
three incubation steps at different temperatures (Figure 3.5). The three steps include:  
 
1. Denaturation: At 950C Double stranded (ds) DNA is denatured to form single stranded (ss) DNA.  
2. Annealing: At 55OC Complementary primers to the target sequence are annealed to the template 
DNA.  
3. Extension: At 72OC, annealed primers are extended by a DNA polymerase (Taq DNA polymerase). 
Each cycle amplifies the target copy. This results in exponential amplification of the original DNA 
fragment. 
  
These three steps make up one cycle of a PCR reaction (Figure 3.6). This cycle is repeated 30 to 40 








Figure 3.5: Presentation of a single PCR cycle, during DNA amplification (Prepared by author). 
 
PCR requires the following to occur:  
• DNA template – contains the sequence of interest 
• Forward and Reverse primers – Binds to the 3’ ends of the forward and reverse strands of the 
target sequence 
• Taq polymerase – Catalyses the synthesis of new strands of DNA complementary to the 
sequence of interest, by adding nucleotides to the ends of the annealed primers  
• Deoxynucleoside triphosphates (dNTPs) –Required Building blocks for the synthesis of new 
DNA strands  
• MgCl2 – Stabilizes DNA and ensures the optimal functioning of Taq polymerase. It acts as a 
cofactor for Taq polymerase  
• Buffer system – Maintains optimum pH for PCR reaction to occur  
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Quantitative PCR (qPCR) can quantify PCR amplicons, unlike conventional PCR which allows for the 
exponential amplification of the DNA target sequence, without the ability to quantify PCR amplicons. 
Quantitative PCR can measure the PCR amplicons generated during each cycle of the PCR process 
(Pestana, Belak et al. 2010). Amplicons are detected using the DNA-intercalating dye, SYBR® Green 
1 (Figure 3.6), which fluoresces intensely when it binds to the minor groves of double stranded DNA. 
The double stranded DNA present is directly proportional to the intensity of the florescence (Arya, 
Shergill et al. 2005). 
 
Simultaneously with the gene of interest, samples are analysed for expression of a house keeping gene, 
and the amount of target DNA is reported relative to the amount of the house keeping gene for each 
sample. Analysis of gene expression is conducted by comparing the target gene with the house-keeping 











RNA was isolated from control, FB1 (24 hrs) and FB1 (10 days) homogenates in 500μl Qiazol after 
being incubated at -800C overnight. The samples were thawed at RT, chloroform (100μl) was then 
added and centrifuged (12,000Xg, 15 min, 40C). The aqueous layer containing the crude RNA was 
transferred into fresh 1.5ml micro-centrifuge tubes and isopropanol (250 μl, 1 h, -800C) was added. The 
samples were centrifuged (12,000Xg, 20 min, 40C), RNA pellets were then washed with 75% ethanol 
(500μl) and centrifuged (7,400Xg, 15 min, 40C). Following removal of ethanol, RNA pellets were air 
dried for approximately 2 hrs and re-suspended in 15μl of nuclease-free water. The RNA was quantified 
using the Nanodrop2000 spectrophotometer (Thermo-Fisher Scientific) and standardised to 1,000 ng/ 
μl. A 20 μl reaction volume containing 1 μl RNA template, 4 μl 5X iScript™ reaction mix, 1 μl iScript 
reverse transcriptase and nuclease free water was used to synthesize cDNA (iScript™ cDNA Synthesis 
kit, Bio-Rad; catalogue no 107-8890). Thermocycler conditions were 250C for 5 min, 420C for 30 min, 
850C for 5 min and a final hold at 40C. 
 
Analysis of gene expression was conducted by employing the SsoAdvanced™ Universal SYBR® 
Green Supermix (catalogue no. #172-5271, Bio-Rad), according to manufacturer’s instructions. The 
mRNA expressions of SOD-2, Tfam, GPx, Nrf-2, Tau, SIRT-3, LONP1 were investigated using specific 
forward and reverse primers (Table 2). GAPDH was used as a house-keeping gene. Reaction volumes 
consisting of the following were prepared: SYBR green (5μl), forward primer (1μl), reverse primer 
(1μl), nuclease free water (2μl) and cDNA template (1000ng/μl, 1μl). All reactions were carried out in 
triplicate. 
  
The amplification of samples was done using a CFX96 Touch™ Real-Time PCR Detection System 
(Bio-Rad). The initial denaturation occurred at 95°C (8 min), followed by 40 cycles of denaturation 
[95°C, 15 second (sec)]; annealing (40sec; Temperatures – Table 3.2) and extension (72°C, 30 sec) 
followed by a plate read. The method described by Livak and Schmittgen was employed to determine 
the relative changes in mRNA expression, where 2-ΔΔCT represents the fold change observed in mRNA 
expression (Livak and Schmittgen 2001). The expression of the gene of interest was normalised against 
















































MicroRNA Assay  
 
The total RNA extracted (as previously described) was reverse transcribed using the miScript ® II RT 
Kit (Qiagen, Hilden, Germany; catalogue number 218160) as per manufacturer’s instructions. To 
quantify miRNA levels, miR-141 (MS00001610) miScript Primer Assays was used, while RNU6 
(MS00033740) was used as an internal control (Qiagen, Hilden, Germany). Experimental protocol was 
performed as per manufacturer’s instructions. The reaction was carried out with an initial activation 
step (95oC, 15 min), followed by 40 cycles of denaturation (94oC, 15 sec), annealing (55oC, 30 sec), 
extension (70oC, 30 sec) and a plate read. Assays were conducted using CFX Touch™ Real Time PCR 
Detection System (Bio-Rad). The analysis of data was conducted using the method described by Livak 




3.8 Statistical Analyses  
 
Microsoft Excel 2016 and GraphPad Prism version 5.0 (GraphPad Software Inc., California) were 
employed to perform all statistical analyses. The unpaired t-test with Welch’s Correction was used for 
all assays. All results were represented as the mean ± standard deviation unless otherwise stated. A 

























Chapter 4 – Results 
 
4.1 Western Blot 
 
4.1.1 Antioxidant response 
 
FB1 triggered a response of AO proteins in C57BL/6 mice brain as result of increased ROS production. 
The key regulator of endogenous AO is Nrf2. In Figure 4.1, the protein expression of total Nrf2 and 
pNrf2, were significantly increased after 24hrs exposure and decreased after 10 day exposure to FB1 
(total Nrf2; 24hrs: *p= 0,0144 (Control: 0.5820 ± 0.1453 RBD vs. FB1: 0.8160 ± 0.1174 RBD); 10 
days: **p =0,0094 (Control: 0.5780 ± 0.08817 RBD vs. FB1: 0.5380 ± 0.1640 RBD)) (phosphorylated 
Nrf2; 24hrs: *p= 0,0132 (Control: 0.9203 ± 0.3320 RBD vs. FB1: 0.6603 ± 0.1917 RBD); 10 days: 
*p=0,0462 (Control: 1.150 ± 0.5470 RBD vs FB1: 1.278 ± 0.5192 RBD)). 
 
Figure 4.1: (A)Protein expression of Nrf2 (24hrs: *p=0,0144; 10 days: **p =0,0094), (B) Protein 







4.1.2 Detoxification of peroxides 
 
Catalase (CAT), a common enzyme found in nearly all living organisms, is upregulated during 
oxidative stress and functions to catalyse the decomposition of hydrogen peroxide to water and 
oxygen. FB1 non-significantly increased the protein expression of CAT in mice brain following acute 
(24 hrs: Control: 1.628 ± 0.4824 RBD vs. FB1: 1.426 ± 0.4842 RBD, p= 0,1206; Figure 4.2) and 
significantly increased expression upon prolonged exposure (10 days: Control: 0.9860 ± 0.03027 
RBD vs. FB1: 1.056 ± 0.1428 RBD, **p= 0,0010; Figure 4.2).  
 
 
Figure 4.2: Protein expression of Catalase in mice brain exposed to FB1 for 24hrs (p= 0,1206) and 10 







4.2 Quantitative polymerase chain reaction (qPCR) 
 
4.2.1 Antioxidant response 
 
To validate the expression of Nrf2 observed at the protein level, Nrf2 mRNA expression was 
investigated using qPCR. FB1 significantly decreased the mRNA expression of Nrf2 in mice brain 
following acute (24hrs: ***p= 0,0001; Figure 4.3) and prolonged (10 days: **p= 0,0013; Figure 4.3) 
exposure.  
 
Figure 4.3: mRNA levels of Nrf2 in C57BL/6 mice brain exposed to FB1 for 24hrs (***p= 0,0001) and 











4.2.2 Post transcriptional regulation of Nrf2 
 
MiR-141 inhibits the Keap1-Nrf2 interaction, resulting in Nrf2 being activated and directed into the 
nucleus instead of being degraded by the proteasome. Using qPCR it was determined that FB1 induced 
a significant decrease in miR-141 levels in mice brain following acute (24hrs: **p= 0,0019; Figure 4.4) 
and prolonged (10 days: ***p= 0,0004; Figure 4.4) exposure.   
 
Figure 4.4: MiR-141 expression in C57BL/6 mice brain exposed to FB1 for 24 hrs (**p= 0,0019) and 













4.2.2 Superoxide detoxification 
 
SOD2 converts toxic superoxide, a by-product of the mitochondrial electron transport chain, into 
hydrogen peroxide and diatomic oxygen. SOD2 mRNA expression was investigated using qPCR. The 
results indicate that FB1 significantly decreased the mRNA expression of SOD2 in mice brain following 
acute (24hrs: **p= 0,0070; Figure 4.5) and non-significantly decrease upon prolonged (10 days: 
p=0,2725; Figure 4.5) exposure.   
 
Figure 4.5: mRNA levels of SOD2 in C57BL/6 mice brain exposed to FB1 for 24 hrs (**p= 0,0070) 












4.2.3 Detoxification of peroxides 
 
GPx protects against oxidative damage by reducing free hydrogen peroxide to water. FB1 significantly 
increased the mRNA expression of GPx in acute (24hrs: ***p= 0,0001; Figure 4.6) and prolonged (10 
days: **p= 0,0024); Figure 4.6) exposure. 
 
Figure 4.6: mRNA levels of GPx in C57BL/6 mice brain exposed to FB1 for 24 hrs (***p=0,0001) 














4.2.4 Mitochondrial stress response 
 
Tfam is the transcription factor responsible for mitochondrial DNA stabilization. Tfam mRNA levels 
were significantly decreased upon acute (24hrs: ***p= 0,0003; Figure 4.7) and prolonged (10 days: 
*p= 0,0196; Figure 4.7) exposure to FB1. 
 
Figure 4.7: mRNA levels of Tfam in C57BL/6 mice brain exposed to FB1 for 24 hrs (***p= 0,0003) 












Mitochondrial stress response protein, LONP1 is induced during oxidative and mitochondrial stress. 
FB1 significantly decreased the mRNA expression of LONP1 upon acute (24hrs: ***p= 0,0005; Figure 
4.8) and prolonged (10 days: *p= 0,0117; Figure 4.8) exposure.  
 
Figure 4.8: mRNA levels of LONP1 in C57BL/6 mice brain exposed to FB1 for 24 hrs (***p= 0,0005) 














The mitochondrial stress response gene, SIRT3, is highly expressed during oxidative and mitochondrial 
stress. The expression of SIRT3 mRNA was decreased upon acute (24hrs: p= 0,0594; Figure 4.9) 
exposure to FB1 and significantly increased upon prolonged (10 days: *p= 0,0283; Figure 4.9) exposure 
to FB1. 
 
Figure 4.9: mRNA levels of SIRT3 in C57BL/6 mice brain exposed to FB1 for 24 hrs (p= 0,0594) and 













4.2.5 Expression of neuronal disease related genes 
 
The tau gene regulates self-assembly of tangles of paired helical filaments and straight filaments, which 
are involved in the pathogenesis of Alzheimer's disease and other tauopathies. The mRNA expression 
of tau was significantly reduced upon acute (24hrs: **p=0,0054; Figure 4.10) and prolonged (10 days: 
*p= 0,0273; Figure 4.10) exposure to FB1. 
 
Figure 4.10: mRNA levels of Tau in C57BL/6 mice brain exposed to FB1 for 24 hrs (**p= 0,0054) 












Chapter 5 – Discussion 
 
The mycotoxin, FB1 is a 2B carcinogenic product of ubiquitous soil fungi F. verticilloides and F. 
proliferatum. It is a common  contaminant of maize and maize-based products (Marasas 2001, 
Chuturgoon, Phulukdaree et al. 2015). FB1 can enter the brain by passing through the blood-brain barrier 
due to its  high polarity and small size (Bezuidenhout, Gelderblom et al. 1988). Neurodegenerative 
disorders such as AD has been attributed in part to increased oxidative damage to DNA, of which 
mitochondrial DNA is particularly sensitive to oxidative damage (Mecocci, MacGarvey et al. 1994), 
since mitochondrial DNA lacks protective histone packaging and mitochondrial ETC generates ROS as 
a by-product during energy production (Gao, Laude et al. 2008). 
 
Mitochondrial health is imperative to the brain as this impacts energy output and redox status. The 
mitochondria’s principal function is to generate ATP through the ETC. Although low concentrations of 
ROS are important for  normal physiological functions like gene expression, cellular growth and 
defence  against infection (López-Alarcón and Denicola 2013), the excessive production of ROS can 
have several negative effects. Abnormal production of ROS from the ETC can be caused by inhibition 
of complex I of the ETC (Bratic and Larsson 2013). Previously, it was reported that FB1 inhibited 
complex I of the ETC, thus inducing excessive  ROS production and mitochondrial depolarisation, and 
advancing the oxidative environment (Domijan and Abramov 2011). After incubation of SH-SY5Y 
cells with FB1, Domijan and Abramov observed significantly high levels of ROS (Domijan and 
Abramov 2011). 
 
FB1 promotes the production of free radical intermediates and accelerates chain reactions associated 
with lipid peroxidation which results in FB1-induced injury (Yin, Smith et al. 1998, Lemmer, 
Gelderblom et al. 1999). This is in accordance with other studies conducted both in vivo and in vitro 
(Kouadio, Mobio et al. 2005, Bernabucci, Colavecchia et al. 2011, Wang, Wu et al. 2016). 
ROS such as hydrogen peroxide and hydroxyl radicals were reported to be involved in nucleic acid and 
protein oxidation in rat spleen mononuclear cells following a 48 hr exposure with  FB1 (Mary, Theumer 
et al. 2012). FB1 also downregulates the base excision repair gene, 8-Oxoguanine glycosylase (OGG1), 
in  oesophageal cancer cells (Khan, Phulukdaree et al. 2018) suggesting that OGG1 would not be able 
to reduce DNA damage under oxidative conditions. 
 
Redox homeostasis is dependent on the disassociation of the antioxidant transcription factor, Nrf2, from 
its inhibitor Keap1. MiR-141 functions in the regulation of Keap1 expression at the posttranscriptional 
level (Eades, Yang et al. 2011). The TargetScan5.1 prediction algorithm identified one conserved 
miRNA targeting site within the Keap1 mRNA 3’-UTR, a site complementary to miR-200a and miR-
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141 (which share identical seed sequences) (Eades, Yang et al. 2011). MiR-141 targets the 3’ UTR of 
Keap1 (Eades, Yang et al. 2011), inhibiting the interaction between  Keap1 and Nrf2. The significant 
reduction in the expression of miR-141 (Figure 4.4) after acute and prolonged exposure of mice brain 
to FB1 implies that the Keap1-Nrf2 complex remained intact and Nrf2 was significantly reduced. This 
was confirmed in our study in which the expression of total Nrf2 protein was significantly increased 
upon 24hr exposure to FB1 and significantly reduced upon 10 days exposure (Figure 4.1), whereas the 
mRNA expression of Nrf2 was significantly decreased at both 24 hrs and 10 days (Figure 4.3). The 
phosphorylation of Nrf2 on serine 40 has been associated with an increase in Nrf2 stability and activity. 
The expression of pNrf2 on serine 40 was significantly increased following acute exposure and 
decreased following prolonged exposure to FB1 (Figure 4.1). This implies that despite the increased 
expression of Nrf2 and pNrf2 upon 24hr FB1 exposure, ROS persisted, as indicated by the significant 
reduction in both the mRNA and protein expression of Nrf2 upon 10 days exposure to FB1. 
 
Downregulation of Nrf2 affected the response of enzymatic antioxidants. Radical scavenging 
mechanisms consist of 3 major antioxidant enzymes namely, SOD, CAT and GPx that are regulated by 
Nrf2. These antioxidants are the first to respond to abnormal levels of ROS. Superoxide dismutase acts 
as the first line of defence, catalysing the conversion of O2•- to H2O2, while CAT and GPx further 
detoxify H2O2 to H2O and O2 (Krinsky 1992, Wang, Wu et al. 2016). Inhibition of complex I of ETC 
by FB1 induces the production of ROS  (Bratic and Larsson 2013). SOD2, CAT and GPx work in concert 
to detoxify ROS products (Krinsky 1992, Wang, Wu et al. 2016). The expression of SOD2 was 
significantly downregulated in C57BL/6 mice brain after exposure to FB1 (Figure 4.5), while the 
expression of CAT and GPx were upregulated in mice brain upon exposure to FB1 (Figure 4.2 and 
Figure 4.6, respectively). The reduction of SOD2 mRNA expression in mice brain is in agreement  with 
other studies that noted a its reduction in Balb/c mice and peripheral blood mononuclear cells (PBMC) 
exposed to FB1 (Bernabucci, Colavecchia et al. 2011, Abbes, Ben Salah-Abbès et al. 2016). The 
reduction of SOD2 gene expression at 24hr and 10 days of exposure to FB1, might be considered as the 
result of the well-known inhibitory effect of some mycotoxins on the synthesis of RNA and proteins 
(Eriksen, Pettersson et al. 2004). Upregulation of CAT protein after exposure to FB1, is not enough to 
bring ROS homeostasis when SOD2 is downregulated, Hence SOD2 functions to convert O2•- to H2O2. 
When H2O2 is left unconverted, it is converted to OH•-, resulting in further oxidative damage. GPx 
mRNA, was significantly upregulated after exposure to FB1 upon 24 hrs and 10 days with reduced 
activity without SOD2 aid in ROS elimination. 
It has been demonstrated that FB1 targets the mitochondria, nucleus and nucleolus (Myburg, Needhi et 
al. 2009). Mitochondrial DNA is highly vulnerable to oxidative damage since it lacks protective histone 
packaging and is in close proximity to the ETC (Gao, Laude et al. 2008). DNA complexes in the 
mitochondria may resemble those in their bacterial ancestors (Bogenhagen, Wang et al. 2003). The 
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mtDNA prevents damage by oxidative stress by organising within the nucleoid. Nucleoid components 
are regulated by the transcription factor, Tfam (Gilkerson, Bravo et al. 2013). Tfam is one of the 
regulators of transcription of genes encoded by mtDNA and controls mtDNA copy number (Rantanen, 
Jansson et al. 2001, Noack, Bednarek et al. 2006). Tfam has the ability to bind non-specifically to DNA, 
which is  advantageous since Tfam protects mtDNA by binding directly to the whole genome (Kanki, 
Ohgaki et al. 2004). The significant downregulation of Tfam mRNA expression (Figure 4.7) in mice 
brain after exposure to FB1 for 24hrs and 10 days may be an indication of compromised mtDNA 
replication, leading to mutations, which may result to cancer and neurodegeneration. 
 
Although phosphorylation of Tfam was not measure in this study, from literature it has been reported 
that FB1 activates extracellular signal-regulated kinases (ERK) cascades, which is involved in Tfam 
phosphorylation (Rumora, Domijan et al. 2007, Lu, Lee et al. 2013). Phosphorylated Tfam cannot bind 
to mtDNA and is incapable of protecting mtDNA, leaving it vulnerable to ROS-induced insults and 
genome instability. Phosphorylation of Tfam results in its rapid degradation by LONP1, a primary 
mitochondrial protease which also regulates mtDNA copy number and transcription (Bota and Davies 
2016). The significant downregulation of LONP1 mRNA expression following  exposure to FB1 (Figure 
4.8), indicates increased mitochondrial stress and loss of  mitochondrial integrity (Ngo, Pomatto et al. 
2013).  
 
SIRT3, a mitochondrial deacetylase enzyme, is responsible for activation of LONP1 at the post-
transcriptional level (Bota and Davies 2016). SIRT3 was downregulated after 24hr exposure, but 
significantly upregulated upon 10 days exposure to FB1 (Figure 4.9). SIRT3 is NAD+ dependent, hence 
it acts as an energy sensor in the mitochondria. The requirement of co-factor NAD+ by SIRT3 for the 
deacetylase activity, places SIRT3 at the centre of energy metabolism in the mitochondria (Nogueiras, 
Habegger et al. 2012).  Compromised mitochondria will reduce ATP production, so ATP-dependent 
mechanisms are compromised, such as LONP1 regulation. Furthermore, decreased SOD2 activity 
reduces the detoxification capacity of the mitochondria (Bause and Haigis 2013). 
 
Abnormal tau expression and oxidative stress have been implicated as important pathogenetic events in 
tauopathies including Alzheimer’s disease (AD) (Cente, Filipcik et al. 2006). Human truncated variant 
form of tau protein leads to the accumulation of ROS and sensitizes rat cortical neurons to cell death 
induced by oxidative stress (Cente, Filipcik et al. 2006). The Tau mRNA was significantly 
downregulated at 24hr and 10 days exposure to FB1 (Figure 10). The loss of normal tau MT-stabilizing 
function has been reported to lead to a pathological disturbance in the normal structural and regulatory 
functions of  the cytoskeleton, compromising axonal transport and thus contributes to synaptic 
dysfunction and neurodegeneration (Ballatore, Lee et al. 2007). Nrf2 activation promotes the 
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degradation of tau protein, indicating  that the reduction in  Tau expression contributes to ROS-induced 
damage in mice brain (Jo, Gundemir et al. 2014).  
 
Exposure to FB1 generated oxidative stress in mice brain, inducing mitochondrial and antioxidant 
responses to reduce increased ROS levels. These responses were compromised leading to mitochondrial 
dysfunction and neurodegeneration. However, further research needs to be conducted to determine the 
role of ROS and Nrf2 in FB1 induced neurodegeneration. 
 
5.1 Limitations and Future studies 
The limitation of this study was that ROS was not directly tested. In future it will be much better to 
develop/find novel protocols to measure ROS in vivo. Another interesting area to make this study even 
better, is to conduct gene knockouts and observe the antioxidant response in mice after exposure to FB1. 
 
5.2 Conclusion   
This study provided evidence that exposing mice brain to FB1 upon 24hrs and 10 days, alters antioxidant 
processes. Compromised antioxidant capacity may not have the ability to deal with the excessive ROS, 
which may result from exposure to FB1. Furthermore, mitochondrial survival responses were also 
compromised (downregulated SOD2, Tfam and LONP1), inducing mitochondrial stress. Hence, the 
excessive ROS induced by FB1, and compromised survival responses may be implicated in FB1 
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NQO1 ensures complete oxidation of quinone substrate without the formation of 
semiquinones and species with reactive oxygen radicals. FB1 significantly decreased the 
mRNA expression of NQO1 in mice brain following acute (24hrs: **p= 0,0080; Figure 6) 
and non-significant increase upon prolonged (10 days: p= 0,1292; Figure 6) exposure.  
 
Figure 6: mRNA levels of NGO1 (24hrs: **p= 0,0080; 10 days: p= 0,1292) in mice brain 















HO-1 catalyses the degradation of heme and is expressed primarily during oxidative stress. 
FB1 significantly decreased the mRNA expression of HO-1 in mice brain following acute 
(24hrs: ***p= < 0.0001; Figure 7) and prolonged (10 days: ***p= < 0.0001; Figure 7) 
exposure.  
 
Figure 7: mRNA levels of HO1 (24hrs: ***p= < 0.0001; 10 days: ***p= < 0.0001) in mice 















MiR-200a inhibits the Keap1-Nrf2 interaction, preventing Nrf2 from degradation by the 
proteasome. Using qPCR it was determined that FB1 induced a significant increase in miR-
200a levels in mice brain following acute (24hrs: ***p< 0.0001; Figure 8) and prolonged (10 
days: **p= 0,0051; Figure 8) exposure.   
 
 
Figure 8: MiR-200a expression in C57BL/6 mice brain exposed to FB1 for 24 hrs (***p< 
















Figure 9: Standard curve displaying known concentrations of bovine serum albumin (BSA) 
used to determine the concentration of protein present in each sample 
